FDA applicant
Ucp Biosciences, Inc.
FDA records 14 decisions for Ucp Biosciences, Inc. (San Jose, CA) from 2005 to 2016: 14 510(k) clearances. Most are in product codes DKZ (Enzyme Immunoassay, Amphetamine) and LFG (Radioimmunoassay, Tricyclic Antidepressant Drugs). Its devices cite 8 predicates, 6 of them its own earlier devices. No recall is linked to its devices.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Ucp Biosciences, Inc.’s devices, and how often a recall has named them.
FDA decisions per year
1in 2016
2026 so far, outlined.
Recalls per year
No recall linked to its devices since 2007.
Planning a device like Ucp Biosciences, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report